Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719755 · ClinicalTrials.gov registry record · NA
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
A NA study of Hysterectomy, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT03719755: Completed NA study of Hysterectomy, sponsored by Mayo Clinic.
NCT03719755 is a NA study of Hysterectomy that has completed, run by Mayo Clinic. The registered enrollment target is 152 participants, above the 121-participant average among 8 other Hysterectomy trials with a reported enrollment target (26% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03719755, a NA study of Hysterectomy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
Our study will compare the rates of postoperative urinary tract infections (UTI) between patients who undergo cystoscopy using 50% dextrose injection plus bladder washout versus normal saline after hysterectomy for benign indications. Primary outcome will be rates of urinary tract infections at 6-9 days post-operatively. This will be defined as a urine culture yielding greater than 100,000 gram-negative colony-forming units per milliliter.
Primary Outcome
be rates of urinary tract infections at 6-9 days post-operatively. This will be defined as a urine culture yielding greater than 100,000 gram-negative colony-forming units per milliliter
Conditions Studied
Interventions
- PROCEDURE 50% dextrose
- PROCEDURE Normal Saline
Study Locations (1)
Arizona
- Mayo Clinic - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2024-12-30 |
| Phase | NA |
What the finished NCT03719755 record still lists
NCT03719755 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, above the 121-participant average among 8 other Hysterectomy trials with a reported enrollment target (26% higher).
The record links to 1 condition, with Hysterectomy appearing as the primary indexed condition, and to 2 interventions - of which 50% dextrose is the first listed.
NCT03719755 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03719755 about?
NCT03719755 is a clinical study titled "Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid". Our study will compare the rates of postoperative urinary tract infections (UTI) between patients who undergo cystoscopy using 50% dextrose injection plus bladder washout versus normal saline after hysterectomy for benign indications. Primary outcome will be rates of urinary tract infections at 6-9 ...
What is the current status of trial NCT03719755?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2018-02-01. Estimated completion is 2024-12-30.
What conditions does trial NCT03719755 study?
This clinical trial studies the following conditions: Hysterectomy.
What interventions are being tested in trial NCT03719755?
The interventions under investigation include: 50% dextrose (PROCEDURE), Normal Saline (PROCEDURE).
Who is sponsoring clinical trial NCT03719755?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03719755 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hysterectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03719755's enrollment target sits among peer trials
152 3rd of 8 higher than 6 of 8 other Hysterectomy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hysterectomy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bilateral Oophorectomy Versus Ovarian Conservation
COMPLETED · NA
-
Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy
COMPLETED · NA
-
The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures
COMPLETED · NA
-
NAC vs Placebo on Opioid Use for Hysterectomy
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Vaginal Cuff Anesthesia and Post-Operative Pain Medication Use
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI